LICENSE CATEGORIES
AVAILABLE LICENSES
LICENSE INFORMATION

Current News Articles

Parvus Therapeutics Enters into Worldwide Collaboration and License Agreement with Genentech to Develop Navacim Therapeutics for the Treatment of Autoimmune Diseases

Parvus Therapeutics, a biopharmaceutical company focused on the development of disease-specific immunoregulatory medicines to treat autoimmune diseases without impairing normal immunity, has entered i...

READ MORE

University of Calgary discovery of potential treatment for autoimmune diseases takes step forward

Click to Read Full Article

READ MORE

Secret sauce: UCalgary researchers turn greenhouse gases into carbon fibre

New method sees multiple uses including replacing metal in cars and airplanes, wind turbines, battery manufacturing, and construction

READ MORE

Direct-C receives Sustainable Development Technology Canada grant

New pilot fund supports Canada's most promising early-stage cleantech entrepreneurs.

READ MORE

Makena Resources Inc. Announces Increase to Previously Announced Private Placement, Strategic Investment and Update of Business Combination with BioCan Technologies Inc., and Epimeron Inc., to form Willow Biosciences Inc.

Makena increases the size of its previously announced private placement of common shares and units from $15 million to $28.5 million, including an investment of $12 million units by Tuatara Capital. ...

READ MORE